Link to medical articles on PubMed using PMIDs (PubMed Identifiers)

-

Comments

Post a Comment

Popular posts from this blog

LICENSING PROCESS

-
The licensing plan First, you need to write down a specific plan. More specifically: 1. Develop a strategy. Will it be an exclusive or non-exclusive license? Will it be limited to various fields? Will it augment sales after your company launches the product? Will you be licensing a limited number licensees or staging them in? What incentives have you considered? 2. Do a SWOT analysis. This is a term used by licensing experts which means you need to analyze and evaluate your intellectual property’s Strengths, Weaknesses, Opportunities and Threats. This is important, because your licensees will do this and if you’re not prepared, you’ll not be able to handle their questions. With these two steps completed, you will want to start taking action. Next: 1. Find licensees. Use New Product Summaries and the methods discussed in the web pages on marketing inventions. 2. Research interested candidates. Once a candidate is identified, research it to better understand it. 3. Start with a term shee...
Read more

USTPO - Global Patent Search Network - China Patent Collection

-
As a result of cooperative effort between the United States Patent and Trademark Office (USPTO) and State Intellectual Property Office (SIPO) of the People’s Republic of China, Chinese patent documentation is now available for search and retrieval from the USPTO website via the Global Patent Search Network. This tool will enable the user to search Chinese patent documents in the English or Chinese language. The data available include fulltext Chinese patents and machine translations. Also available are full document images of Chinese patents which are considered the authoritative Chinese patent document. Users can search documents including published applications, granted patents and utility models from 1985 to 2012. More
Read more

Suven Life Sciences Patents

-
Suven Life Sciences, a Hyderabad-based biopharmaceutical company specialising in central nervous system (CNS) diseases, got patent for the candidate (SUVN-502), achieved through internal discovery efforts of Suven, has been validated in all the nine member countries of Eurasia (including Russia) and 37 member countries of Europe including major markets like Germany, Switzerland, Denmark, Spain, France, UK, Italy, the Netherlands, Poland, Sweden and Finland Read More
Read more